Jay R. Luly
2011
In 2011, Jay R. Luly earned a total compensation of $610.2K as President and Chief Executive Officer at Enanta Pharmaceuticals.
Compensation breakdown
| Bonus | $173,491 |
|---|---|
| Option Awards | $35,208 |
| Salary | $397,110 |
| Other | $4,421 |
| Total | $610,230 |
Luly received $397.1K in salary, accounting for 65% of the total pay in 2011.
Luly also received $173.5K in bonus, $35.2K in option awards and $4.4K in other compensation.
Rankings
In 2011, Jay R. Luly's compensation ranked 7,430th out of 10,747 executives tracked by ExecPay. In other words, Luly earned more than 30.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,430 out of 10,747 | 31st |
Division Manufacturing | 2,716 out of 3,958 | 31st |
Major group Chemicals And Allied Products | 666 out of 1,034 | 36th |
Industry group Drugs | 464 out of 782 | 41st |
Industry Pharmaceutical Preparations | 357 out of 567 | 37th |
Source: SEC filing on January 10, 2014.
Luly's colleagues
We found two more compensation records of executives who worked with Jay R. Luly at Enanta Pharmaceuticals in 2011.
News
Enanta Pharmaceuticals CEO Jay Luly's 2022 pay jumps 37% to $7.3M
January 20, 2023
Enanta Pharmaceuticals CEO Jay Luly's 2021 pay rises 2% to $5.3M
January 21, 2022
Enanta Pharmaceuticals CEO Jay Luly's 2020 pay rises 16% to $5.2M
January 21, 2021
Enanta Pharmaceuticals CEO Jay Luly's 2019 pay slips 1% to $4.5M
January 17, 2020
Enanta Pharmaceuticals CEO Jay Luly's 2018 pay rises 5% to $4.5M
January 18, 2019